The core-binding factor leukemias: lessons learned from murine models.
about
The epigenetic landscape of acute myeloid leukemiaAML1/Runx1 is important for the development of hindbrain cholinergic branchiovisceral motor neurons and selected cranial sensory neuronsThe molecular basis of congenital thrombocytopenias: insights into megakaryopoiesis.Comprehensive mutational profiling of core binding factor acute myeloid leukemia.Folylpolyglutamate synthetase gene transcription is regulated by a multiprotein complex that binds the TEL-AML1 fusion in acute lymphoblastic leukemia.Interleukin-3 receptor in acute leukemia.Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemiaAdvances in molecular genetics and treatment of core-binding factor acute myeloid leukemiaCore-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.FLT3 inhibitors in the treatment of acute myeloid leukemia: the start of an era?Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia.High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations.Commitment issues: linking positive selection signals and lineage diversification in the thymus.FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.Steroid resistance in leukemia.Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors.Single-nucleotide polymorphism-array improves detection rate of genomic alterations in core-binding factor leukemia.Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal.Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain.SNP-array lesions in core binding factor acute myeloid leukemia.Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities.Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.
P2860
Q21284742-45D32251-43AE-40CB-9760-BE558BCE2780Q28505845-4EFCB390-C2EE-4CC1-894C-56C8E820832CQ33368674-2510B1D5-5A50-4CCD-851F-9F418158A770Q33758306-3DDCDC16-F8EC-4EFD-9595-0BE6144A69D6Q34161064-2A056206-9DB1-4F19-BB20-7883BF1B48D6Q34283145-1B71C33E-C3D6-49C2-B221-9C9C07E38AFAQ34420787-7EBC8442-9608-4BC4-80DC-F704B93BB233Q34598109-B5D455E5-7793-42E9-9AD1-0DD49A637222Q34663691-5B1A228A-983C-43FC-8A92-AD6A584B1F6EQ35048217-281C9582-8DD5-4151-8622-B3BB560BCACAQ35776442-C14BFFDC-5C17-483C-98CE-87AD13C4E013Q35849281-03FB02F7-B13D-4183-9742-77FD7D6F256AQ36382781-614D0380-230E-4D12-98C5-9EF952E11D15Q36407239-90A1D643-9DD7-476B-B511-2C1EC6654CC1Q38187422-1C48DFFE-8D6C-46DE-BDCA-E39DA9B06A88Q38263126-D05DA7E8-5D0C-40A9-AE7D-EAC54343796BQ38315894-A700BDB7-269A-4F19-A7AA-75D64F281EB2Q44902447-B58944C2-047B-44DA-B489-263BE6CF7BA5Q45061050-97DFA4D8-E95E-4261-8030-65F18FE6A6AAQ50014393-D4B10223-5F31-4BB9-8AD5-1587F9758B81Q51632377-56DA9E6D-3715-4B08-88F3-FD0435237952Q54397201-8BF18A62-6D41-4502-939A-40C473FEF897
P2860
The core-binding factor leukemias: lessons learned from murine models.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The core-binding factor leukemias: lessons learned from murine models.
@ast
The core-binding factor leukemias: lessons learned from murine models.
@en
type
label
The core-binding factor leukemias: lessons learned from murine models.
@ast
The core-binding factor leukemias: lessons learned from murine models.
@en
prefLabel
The core-binding factor leukemias: lessons learned from murine models.
@ast
The core-binding factor leukemias: lessons learned from murine models.
@en
P1476
The core-binding factor leukemias: lessons learned from murine models.
@en
P2093
James R Downing
P356
10.1016/S0959-437X(02)00018-7
P577
2003-02-01T00:00:00Z